Existing clinical assessments for upper-limb motor rehabilitation poststroke pose limitations as end points for efficient clinical trials. This study aimed to develop a digital metric for assessing motor recovery using accelerometer data collected in naturalistic environments. We constructed the digital arm performance scale (DAPS) by analyzing ∼23,000 hours of data from 215 participants, including healthy individuals and subacute and chronic stroke survivors. We decomposed continuous upper-limb accelerometer data into lower-level movement segments, from which key features were extracted and aggregated using a linear mixed-effects model to produce an interpretable digital biomarker. DAPS demonstrated excellent reliability, sensitivity, concurrent validity, known-groups validity, discriminant validity, and responsiveness. Power analysis indicated that DAPS could reduce the required sample size for clinical trials with upper-limb motor recovery end points by more than 60% compared with traditional assessments. These findings highlight the potential of DAPS as a low-burden, scalable assessment tool for upper-limb motor recovery, with potential applications in both clinical trials and practice.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: